• 1
    Inoue K, Fukuhara H, Shimamoto T et al. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for non-muscle invasive bladder cancer. Cancer 2012; 118: 106274.
  • 2
    Denzinger S, Burger M, Walter B et al. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study. Urology 2007; 69: 6759.
  • 3
    Ogino T, Kobuchi H, Munetomo K et al. Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells. Mol. Cell. Biochem. 2011; 358: 297307.
  • 4
    Matsuyama H, Yamamoto Y, Nagao K, Ohmi C, Sakano S, Sasaki K. Cytogenetic analysis of false-positive mucosa by photodynamic diagnosis using 5-aminolevulinic acid – possible existence of premalignant genomic alterations examined by in vitro experiment. Oncology 2009; 76: 11825.
  • 5
    Lengauer C, Kinzler K, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396: 6439.
  • 6
    Hartmann A, Schlake G, Zaak D et al. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. Cancer Res. 2002; 62: 80918.